title: Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study.
authors.forename: Luca
authors.initials: L
authors.lastname: De Nicola
authors.forename: Pasquale
authors.initials: P
authors.lastname: Zamboli
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Bellizzi
authors.forename: Giovanna
authors.initials: G
authors.lastname: Stanzione
authors.forename: Domenico
authors.initials: D
authors.lastname: Russo
authors.forename: Felice
authors.initials: F
authors.lastname: Nappi
authors.forename: Maristella
authors.initials: M
authors.lastname: Minco
authors.forename: Paolo
authors.initials: P
authors.lastname: Chiodini
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Conte
authors.forename: Roberto
authors.initials: R
authors.lastname: Minutolo
mesh_terms: D000577:Amides / Q000627:therapeutic use*; D005500:Follow-Up Studies; D005650:Fumarates / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011446:Prospective Studies; D011507:Proteinuria / Q000188:drug therapy* / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000187:drug effects*; D016896:Treatment Outcome
chemical_list: D000577:Amides; D005650:Fumarates; C446481:aliskiren